CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Woojung BIO Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Woojung BIO Inc
Woojung Bio New Drug Cluster
593-8, Dongtangiheung-ro
Phone: +82 318889341p:+82 318889341 HWASEONG, 18469  South Korea Ticker: 215380215380
Business Summary
Woojung Bio Inc is a Korea-based company principally engaged in the biological business. The Company operates its business through two segments. The Infection Control Business segment is engaged in the manufacture and sale of reagents, breeding equipment, hydrogen peroxide sterilizers and other products. The Biological Business segment is engaged in the provision of test agency, research service and passage management services.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
3569 General industrial machinery and equipment, not elsewhere classified
8734 Testing laboratories
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Byeong NyeonCheon 59 4/24/2017 3/7/2017
Internal Auditor Sang CheolAhn 49
Internal Auditor GeonOh 59 3/7/2017 3/7/2017
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 147 (As of 12/31/2023)
Outstanding Shares: 13,480,286 (As of 2/23/2024)
Shareholders: 12,569
Stock Exchange: KDQ
Fax Number: +82 318889368


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024